Raffles Medical eyes China healthcare growth but stays prudent on expansions

PRIVATE healthcare provider Raffles Medical Group has its eyes fixed on continuing to drive growth, even as it grapples with a slowdown in medical tourism amid the Covid-19 pandemic.

When Singapore shut its borders in early 2020, foreigners seeking medical help here had to be turned away. Private healthcare players who relied heavily on medical tourism turned to other avenues to get their care to overseas patients, including online consultations and delivering medication straight to patients’ homes.

While some companies would have baulked at the sudden shift in operations, Raffles Medical took the changes in stride.